Pathogen: clinical or host-associated sample from ... - BioSample

Pathogen: clinical or host-associated sample from Escherichia coli

Organism: Escherichia coli
cellular organisms; Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Enterobacteriaceae; Escherichia

Attributes

Submission: Centers for Disease Control and Prevention, Brian Yoo; 2019-06-04

Antibiogram
Antibiotic	Resistance phenotype	Measurement sign	Measurement	Measurement units	Laboratory typing method	Testing standard
amikacin	intermediate	==	32	mg/L	MIC	CLSI
ampicillin	resistant	>	32	mg/L	MIC	CLSI
ampicillin-sulbactam	intermediate	==	16/8	mg/L	MIC	CLSI
aztreonam	intermediate	==	8	mg/L	MIC	CLSI
cefazolin	resistant	>	8	mg/L	MIC	CLSI
cefepime	susceptible	<=	0.5	mg/L	MIC	CLSI
cefotaxime	resistant	==	8	mg/L	MIC	CLSI
cefoxitin	resistant	>	16	mg/L	MIC	CLSI
ceftazidime	resistant	==	16	mg/L	MIC	CLSI
ceftazidime-avibactam	susceptible	<=	0.5/4	mg/L	MIC	CLSI
ceftolozane-tazobactam	susceptible	<=	0.5/4	mg/L	MIC	CLSI
ceftriaxone	resistant	==	16	mg/L	MIC	CLSI
ciprofloxacin	resistant	>	8	mg/L	MIC	CLSI
colistin	not defined	==	0.5	mg/L	MIC	CLSI
doripenem	susceptible	<=	0.12	mg/L	MIC	CLSI
ertapenem	susceptible	<=	0.12	mg/L	MIC	CLSI
gentamicin	susceptible	==	4	mg/L	MIC	CLSI
imipenem	susceptible	<=	0.5	mg/L	MIC	CLSI
levofloxacin	resistant	>	8	mg/L	MIC	CLSI
meropenem	susceptible	<=	0.12	mg/L	MIC	CLSI
minocycline	intermediate	==	8	mg/L	MIC	CLSI
piperacillin-tazobactam	susceptible	<=	4/4	mg/L	MIC	CLSI
plazomicin	intermediate	==	4	mg/L	MIC	CLSI
tetracycline	resistant	>	32	mg/L	MIC	CLSI
tigecycline	susceptible	<=	0.5	mg/L	MIC	CLSI
tobramycin	resistant	>	16	mg/L	MIC	CLSI
trimethoprim-sulfamethoxazole	susceptible	<=	0.5/9.5	mg/L	MIC	CLSI